Next Century Growth Investors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Next Century Growth Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$548.35 - $738.84 $349,298 - $470,641	637 Added 29.84%	2,772 $1.64 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.53 Million - $1.79 Million	-2,567 Reduced 54.59%	2,135 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1,086 - $1,341	-2 Reduced 0.04%	4,702 $2.97 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $83,212 - $98,303	-176 Reduced 3.61%	4,704 $2.63 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $2.18 Million - $2.68 Million	4,880 New	4,880 $2.31 Million
Q4 2017 Feb 13, 2018	SELL	$358.63 - $469.95 $608,595 - $797,505	-1,697 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$431.38 - $504.0 $939,977 - $1.1 Million	-2,179 Reduced 56.22%	1,697 $758,000
Q2 2017 Aug 14, 2017	BUY	N/A	3,876	3,876 $1.9 Million

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.